Patients News | pharmaphorum

News

Kyverna rises on stiff person syndrome data

Kyverna hopes to file CAR-T therapy miv-cell for approval as the first therapy for stiff person syndrome, a rare and debilitating autoimmune disease.

News

J&J's run of talc lawsuit setbacks continues

A California jury has awarded $40m in damages to two women who sued Johnson & Johnson, claiming that its talc products caused ovarian cancer.

News

Raymond Chua of Singapore's Health Sciences Authority and Lawrence Tallon of the UK Medicines and Healthcare products Regulatory Agency.

UK teams up with Singapore on healthtech regulation

A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.

News

Woman wears neuro headset for depression

FDA clears first at-home device for depression

Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.

News

Agreement reached on EU's new pharma legislation

Agreement has been reached on the reform of EU pharma legislation, but industry thinks it does not go far enough to restore the bloc's global status.

News

Hims & Hers launches weight-loss business in UK

Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering Wegovy, Mounjaro, and OTC option Orlos.

Kyverna rises on stiff person syndrome data

J&J's run of talc lawsuit setbacks continues

UK teams up with Singapore on healthtech regulation

FDA clears first at-home device for depression

Agreement reached on EU's new pharma legislation

Hims & Hers launches weight-loss business in UK

ASCO 2026: All about DNA damage response, with Luke Piggot

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks